A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone

PURPOSE: The aim of this study was to identify a noninvasive urinary marker for prostate cancer (PCa) diagnosis and to validate the clinical performance of this novel urinary mRNA signature using the droplet digital polymerase chain reaction (ddPCR) approach. MATERIALS AND METHODS: A gene expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Ho Won, Lee, Hee Youn, Byun, Young Joon, Jeong, Pildu, Yoon, Jin Sun, Kim, Dong Ho, Kim, Won Tae, Kim, Yong-June, Lee, Sang-Cheol, Yun, Seok Joong, Kim, Wun-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329636/
https://www.ncbi.nlm.nih.gov/pubmed/32665998
http://dx.doi.org/10.4111/icu.2020.61.4.411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329636/
https://www.ncbi.nlm.nih.gov/pubmed/32665998
http://dx.doi.org/10.4111/icu.2020.61.4.411

Ejemplares similares